Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never became a big part of the genetic testing company’s business, but it is getting ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

After years of limited activity, the digital health sector is finally showing signs of life in the public markets. Only a few companies have filed to go public in recent years, including Waystar ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both ...

Data and system integration is less glamorous compared to the latest conversations on how AI can improve healthcare delivery and outcomes. However, for AI or other technologies to be successful, a ...

Every minute matters in healthcare. Outdated systems and disjointed workflows can stall the flow of critical clinical information. Today’s providers often face the challenge of retrieving vital ...